EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Ginkgo Bioworks Holdings's enterprise value is $971.6 Mil.
Ginkgo Bioworks Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $251.5 Mil. Therefore, Ginkgo Bioworks Holdings's EV-to-Revenue for today is 3.86.
The historical rank and industry rank for Ginkgo Bioworks Holdings's EV-to-Revenue or its related term are showing as below:
DNA'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.78 Med: 7.22 Max: 122.37
Current: 3.86
During the past 5 years, the highest EV-to-Revenue of Ginkgo Bioworks Holdings was 122.37. The lowest was 2.78. And the median was 7.22.
DNA's EV-to-Revenue is ranked better than 65.54% of 1033
companies
in the Biotechnology industry
Industry Median: 7.66
vs DNA: 3.86
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ginkgo Bioworks Holdings's EV-to-Revenue
For the Biotechnology subindustry, Ginkgo Bioworks Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ginkgo Bioworks Holdings's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Ginkgo Bioworks Holdings's EV-to-Revenue falls into.
Ginkgo Bioworks Holdings's current Enterprise Value is $971.6 Mil.
Ginkgo Bioworks Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $251.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ginkgo Bioworks Holdings's share price for today is $0.8601.
Ginkgo Bioworks Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.13.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ginkgo Bioworks Holdings EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Ginkgo Bioworks Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Business Description
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry and Biosecurity. The Biosecurity segment generates the majority of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DNA has been successfully added to your 